Treatment with obinutuzumab leads to worse outcomes in haematological patients diagnosed with Omicron variant COVID-19

Tali Shafat, Daniel Grupel, Tzvika Porges, Itai Levi, Yael Yagel, Lior Nesher

Research output: Contribution to journalLetterpeer-review

10 Scopus citations
Original languageEnglish
Pages (from-to)826-829
Number of pages4
JournalBritish Journal of Haematology
Volume198
Issue number5
DOIs
StatePublished - 1 Sep 2022
Externally publishedYes

Keywords

  • COVID-19
  • Haematological malignancies
  • SARS-CoV-2 infection
  • anti-CD20 monoclonal antibodies
  • obinutuzumab
  • rituximab

ASJC Scopus subject areas

  • Hematology

Cite this